Previous close | 96.22 |
Open | 95.28 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 93.32 - 96.32 |
52-week range | 93.32 - 96.32 |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | 0.88 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
EQS-News: Redcare Pharmacy N.V. / Key word(s): MiscellaneousSHOP APOTHEKE EUROPE PROMOTED TO THE MDAX. 06.06.2023 / 09:15 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX.Sevenum, the Netherlands, 6 June 2023. SHOP APOTHEKE EUROPE will be promoted to the MDAX, the leading German stock index for mid-sized companies, following the latest index review by global index provider STOXX Ltd.Effective 19 June 2023, SHOP APOTHEKE EUROP
SHOP APOTHEKE EUROPE N.V. / Key word(s): MiscellaneousRedcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.22-May-2023 / 22:59 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.Sevenum
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Joint VentureJoint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland. 11.05.2023 / 19:18 CET/CESTThe issuer is solely responsible for the content of this announcement.Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.Sevenum, the Netherlands, 11 May 2023. The competition authorities in Switzerland and Austria confirmed the approval for t
SHOP APOTHEKE EUROPE N.V. / Key word(s): Joint Venture/Capital IncreaseSHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted11-May-2023 / 19:14 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture grantedSevenum, the Netherlan
Shop Apotheke Europe ( ETR:SAE ) First Quarter 2023 Results Key Financial Results Revenue: €372.1m (up 22% from 1Q...
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Quarter Results/Quarterly / Interim StatementSHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE. 02.05.2023 / 06:45 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE. Total sales up 22% to EUR 372 million. Non-Rx sales growth 23%; outpacing the full-year g
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): AGM/EGMSuccessful Outcome for SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name. 27.04.2023 / 10:11 CET/CESTThe issuer is solely responsible for the content of this announcement.Successful Outcome of SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.Sevenum, the Netherlands, 27 April 2023. Yesterday's Annual General Meeting of SHOP APOTHEKE EURO
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Preliminary Results/Quarterly / Interim StatementSHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021. 05.04.2023 / 06:45 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021. Q1 total sales up 22% year over year to EUR 371 million. Non-Rx sales growth 23%. Customer satisfaction remains very high with NPS above 70
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Joint Venture/Strategic Company DecisionSHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland. 30.03.2023 / 06:59 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland. Sevenum, the Netherlands, 30 March 2023. A
SHOP APOTHEKE EUROPE N.V. / Key word(s): Joint Venture/Corporate ActionSHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.30-March-2023 / 06:58 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EU
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): AGM/EGMSHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023 15.03.2023 / 18:34 CET/CESTThe issuer is solely responsible for the content of this announcement.NOT FOR DIRECT OR INDIRECT RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, CANADA, SOUTH AFRICA, AUSTRALIA OR JAPAN.SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023Sevenum,
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): PersonnelSHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO. 15.03.2023 / 18:33 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO.Sevenum, the Netherlands, 15 March 2023. The Supervisory Board of SHOP APOTHEKE EUROPE has appointed Olaf Heinrich as new CEO as of 1 August 2023, subject to approval by the AGM. In this position, he will succeed Stefan Feltens,
SHOP APOTHEKE EUROPE N.V. / Key word(s): PersonnelSHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO15-March-2023 / 18:30 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEOSevenum, 15 March 2023. SHOP APOTHEKE EUROPE N.V. (SAE.DE), hereby announ
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Annual ReportSHOP APOTHEKE EUROPE 2022: RECORD SALES OF EUR 1.2 BILLION AND SIGNIFICANTLY IMPROVED MARGINS IN THE SECOND HALF OF THE YEAR. 07.03.2023 / 06:30 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE 2022: RECORD SALES OF EUR 1.2 BILLION AND SIGNIFICANTLY IMPROVED MARGINS IN THE SECOND HALF OF THE YEAR. Group sales up 14% to EUR 1.2 billion in 2022. Full year guidance provided at the start
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): PersonnelCEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE. 06.03.2023 / 18:17 CET/CESTThe issuer is solely responsible for the content of this announcement.CEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE.Sevenum, 6 March 2023. SHOP APOTHEKE EUROPE’s CEO, Stefan Feltens, has informed Björn Söder, chairman of the Supervisory Board that for purely personal reasons, he will not be available for another term after the expiration of his c
SHOP APOTHEKE EUROPE N.V. / Key word(s): PersonnelSHOP APOTHEKE EUROPE N.V.: No prolongation of his term as CEO by Stefan Feltens06-March-2023 / 18:15 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE N.V.: No prolongation of his term as CEO by Stefan FeltensSevenum, 6 March 2023 – SHOP APOTHEKE EUROPE
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Preliminary Results/Development of SalesSHOP APOTHEKE EUROPE: STRONG ORGANIC GROWTH CONTINUES. 11.01.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE: STRONG ORGANIC GROWTH CONTINUES. Q4 total sales up by 14% year over year to EUR 328 million. Full year 2022 double-digit sales growth of 14% achieved; record EUR 1.2 billion total sales. Non-Rx sales growth 17% for the full year; 2022
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): SustainabilityAt the VISION 2045 Summit alongside the COP 27: CEO Stefan Feltens presents SHOP APOTHEKE EUROPE’s NET ZERO 2040 Strategy in Sharm El Sheikh. 10.11.2022 / 09:00 CET/CESTThe issuer is solely responsible for the content of this announcement.At the VISION 2045 Summit alongside the COP 27:CEO Stefan Feltens presents SHOP APOTHEKE EUROPE’s NET ZERO 2040 Strategy in Sharm El Sheikh.Sevenum, November 10, 2022. From 07 to 09 November 2022,
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Interim Report/9 Month figuresSHOP APOTHEKE EUROPE: SOLID AND SUCCESSFUL QUARTER, FULLY IN LINE WITH GUIDANCE. BETTER MARGINS AND CONTINUED MARKET SHARE GAINS. 31.10.2022 / 06:29 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE: SOLID AND SUCCESSFUL QUARTER, FULLY IN LINE WITH GUIDANCE. BETTER MARGINS AND CONTINUED MARKET SHARE GAINS. Group sales up 20% to EUR 285 million in Q3 (9M up 14% to EUR
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): 9 Month figures/Preliminary ResultsSHOP APOTHEKE EUROPE: STRONG OPERATIONAL PERFORMANCE, GROWING FAST AND IMPROVING THE BOTTOM LINE. 05.10.2022 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE: STRONG OPERATIONAL PERFORMANCE, GROWING FAST AND IMPROVING THE BOTTOM LINE. Non-Rx sales growth 22% in Q3 (9M 18%). Total sales growth 20% to EUR 285 million in Q3 (9M 14% to EUR 877M). Customer Ne
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): SustainabilitySHOP APOTHEKE EUROPE presents its NET ZERO Strategy 2040 at this year's Retail Media Summit. 04.10.2022 / 09:05 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE presents its NET ZERO Strategy 2040 at this year's Retail Media Summit.Sevenum, October 4, 2022. SHOP APOTHEKE EUROPE's fourth Retail Media Summit took place last Thursday for the first time as a hybrid event in Dusseldorf.
EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Expansion/MiscellaneousSHOP APOTHEKE EUROPE: New Italian distribution centre fully operational. 20.09.2022 / 09:00 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE: New Italian distribution centre fully operational.Sevenum, September 20, 2022. SHOP APOTHEKE EUROPE looks back on the successful opening of its new distribution centre in Milan, Italy. After the first package had left the site on July
DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): MiscellaneousSHOP APOTHEKE EUROPE READY FOR THE NEXT PHASE OF E-PRESCRIPTIONS IN GERMANY. 02.09.2022 / 09:52 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE READY FOR THE NEXT PHASE OF E-PRESCRIPTIONS IN GERMANY. Roll-out of electronic prescriptions in Germany started on 1 September. Support ambitious quality criteria set by Gematik shareholders. SHOP APOTHEKE EUROPE is ready to serve the e-pre
DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Half Year Report/Half Year ResultsSHOP APOTHEKE EUROPE CONFIRMS FULL-YEAR TOP AND BOTTOM LINE GUIDANCE AFTER STRONG H1 SALES PERFORMANCE. 03.08.2022 / 06:45 The issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE CONFIRMS FULL-YEAR TOP AND BOTTOM LINE GUIDANCE AFTER STRONG H1 SALES PERFORMANCE. Total Group sales in H1 up 11% reaching EUR 592 million; further growth acceleration in Q2 to 15%. Non-Rx sales grew
DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Preliminary Results/Development of SalesSHOP APOTHEKE EUROPE ACCELERATES TOTAL SALES GROWTH TO 15% – FULL YEAR GUIDANCE RE-CONFIRMED. 05.07.2022 / 07:00 The issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE ACCELERATES TOTAL SALES GROWTH TO 15% – FULL YEAR GUIDANCE RE-CONFIRMED. Everything-but-Rx (non-Rx) sales up 18% in Q2, fully on track with guidance for the year (H1 up 16%). Total sales up 15% to EUR 287